Main

Researchers were awarded a 2.1 million USD grant that will fund the next step of the study.

Research suggests a significant decrease in immune response a few months after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine

The award was granted by the Coalition of Rare Diseases in Israel for his dedication to the well-being of patients

Around 100 Sheba Medical Center personnel man the 66-bed hospital round-the-clock, treating up to 150 patients simultaneously.

According to a new Sheba study, a combined immunotherapy regimen is more effective against metastatic melanoma.

New Sheba research suggests non-invasive stool samples may replace colonoscopies in many cases. Click here to learn more.

Clinicians from Sheba will work with peers from the Murdoch Children’s Research Institute to identify the root cause of Rett syndrome, a rare but debilitating disease.

A new Sheba Medical Center study finds no link between COVID-19 vaccines and infertility. Click here to learn more.

New research has uncovered both the cause and a possible treatment for ALS, a degenerative muscle condition that affects tens of thousands of people worldwide.